Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes with cardiovascular diseaseau-amcau-racp

A 62-year-old man with type 2 diabetes and established coronary artery disease (previous NSTEMI) has HbA1c 7.8% (62 mmol/mol) on maximal tolerated Metformin. eGFR is 70 mL/min/1.73 m². According to contemporary Australian recommendations, which additional medication class should be prioritised for cardiovascular benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.